Phibro Animal Health Q3 2024 Adj EPS $0.31 Beats $0.29 Estimate, Sales $263.200M Beat $254.825M Estimate
Portfolio Pulse from Benzinga Newsdesk
Phibro Animal Health (NASDAQ:PAHC) reported Q3 2024 adjusted EPS of $0.31, surpassing the $0.29 estimate, with sales of $263.2M also beating the $254.825M forecast. This represents a 6.9% increase in EPS and a 7.12% increase in sales over the same period last year.
May 08, 2024 | 9:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Phibro Animal Health reported a strong Q3 2024 with adjusted EPS of $0.31 and sales of $263.2M, both exceeding analyst expectations.
Beating both EPS and sales estimates indicates strong financial health and operational efficiency, likely leading to positive investor sentiment and a potential increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100